FDA (Tag Archives)
Subscribe to PricePlow's Newsletter and FDA Alerts
Ping, Li, and Fleming: The First Three Studies Where DMAA Was Found in Geranium
This is part one of a six page series researching whether DMAA (1,3 dimethylamylamine) is a natural constituent of geranium flowers. All six parts are linked from our main DMAA in Nature / Geranium page.
Note from Mike, Founder of PricePlow
Thanks for joining us. A tremendous amount of research went into these articles, […]
Continue Reading →
Eria Jarensis Extract / N-phenethyl dimethylamine: Advanced PEA Stimulant
In the sports and active nutrition corner of the dietary supplement industry, cutting-edge brands and consumer alike are constantly on the hunt for the “next stimulant”. Something to safely take training and mood to the next level.
That next compound arrived in 2015 by way of N-Phenyldimethylamine or N,N-Dimethylphenethylamine, a constituent of Eria […]
Continue Reading →
Hi-Tech: Will Take DMAA Case to Supreme Court if Necessary
On April 5, 2017, Hi-Tech Pharmaceuticals will issue the following press release regarding the latest updates to their DMAA lawsuit against the FDA (the final paragraph is by far the most interesting, so hang in there):
Hi-Tech’s CEO, Jared Wheat, said he is “going to continue to fight for DMAA until Hell freezes over, and […]
Continue Reading →
Higenamine BANNED by WADA Starting in 2017!
Drug tested athletes pay attention! Today’s blog post is especially for you!
The World Anti-Doping Agency (WADA) recently updated its list of prohibited ingredients for 2017 in The World Anti-Doping Agency International Standard and they’ve added an extremely common popular stimulant to the list: Higenamine (a.k.a. Norcoclaurine).[1] It’s also sometimes labeled as Nelumbo Nucifera […]
Continue Reading →
The 2016 FDA NDI Draft Guidance Document: How To Destroy The ENTIRE Dietary Supplement Industry in 102 Pages
Disclaimer: This article was co-authored by Bruce Kneller and Mike.
On August 12th 2016, the FDA published a new Draft Guidance Document for NDIs (New Dietary Ingredients), in the Federal Register. Since this document is 102 pages long, there is much to discuss.
TL;DRThe FDA’s proposal is nothing short of a multi-pronged attack […]
Continue Reading →
Methylsynephrine FDA Warnings, Hi-Tech Not Reformulating
On March 31, 2016, the FDA issued seven warning letters to supplement companies regarding methylsynephrine: since it does not meet the definition of a dietary supplement, it cannot be sold as one.[1]
Methyl-synephrine is also known as oxilofrine, p-hydroxyephedrine, and 1-Hydroxypholedrine. It’s a known banned substance in most sports due to […]
Continue Reading →
Ephedra Fat Burners in the 2020s: How are they still around?
It’s [year], and something interesting’s happening at several reputable online nutrition stores: an ephedra-based fat burner named Lipodrene remains high on the lists of best-sellers — over a decade after ephedra was apparently banned by the FDA.
What’s going on here? How is ephedra still out there after so many sites say that it’s […]
Continue Reading →
USPLabs Indicted on Major DOJ Charges, Including Money Laundering
Today, the Department of Justice issued statements that USPLabs has been charged with 11 counts related to past transgressions from 2008 through 2013.
The indictment has been made public and can be downloaded below:
justice.gov/opa/file/793706/downloadSeven executives have been charged.
The charges filed against USPLabsThe DOJ charges that,
USPLabs and SK Laboratories (their manufacturer) […]
Continue Reading →
AMP Citrate BANNED in 2015 – FDA Lays the DMBA Hammer Down
UPDATE 2015: The FDA has BANNED AMP CITRATE! They have sent 13 Warning Letters to companies selling AMP Citrate / DMBA. The warning letters are below.
If you’ve been tuned into sports supplements, you’ve possibly heard of an ingredient named AMP citrate (also known as “DMBA”) added to several fat burners and pre-workout supplements […]
Continue Reading →